REPLIGEN CORP Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPLIGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REPLIGEN CORP for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 27 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 86.11 | 946 | 81,460 | 31,096 | 32 K to 31.1 K (-2.95 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 86.86 | 154 | 13,376 | 32,042 | 32.2 K to 32 K (-0.48 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Option Exercise | M | 16.55 | 10,210 | 168,976 | 7,917 | |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Option Exercise | M | 32.40 | 11,735 | 380,214 | 53,240 | |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 86.10 | 1,594 | 137,243 | 226,148 | 227.7 K to 226.1 K (-0.70 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 86.86 | 1,881 | 163,384 | 227,742 | 229.6 K to 227.7 K (-0.82 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Buy | M | 16.55 | 10,210 | 168,976 | 229,623 | 219.4 K to 229.6 K (+4.65 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 90.22 | 1,624 | 146,517 | 219,413 | 221 K to 219.4 K (-0.73 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 91.66 | 8,412 | 771,044 | 221,037 | 229.4 K to 221 K (-3.67 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 92.34 | 1,699 | 156,886 | 229,449 | 231.1 K to 229.4 K (-0.74 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Buy | M | 32.40 | 11,735 | 380,214 | 231,148 | 219.4 K to 231.1 K (+5.35 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 86.60 | 195 | 16,887 | 26,313 | 26.5 K to 26.3 K (-0.74 %) |
Feb 26 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | S | 92.76 | 4,355 | 403,970 | 2,781 | 7.1 K to 2.8 K (-61.03 %) |
Feb 26 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | S | 94.85 | 100 | 9,485 | 7,136 | 7.2 K to 7.1 K (-1.38 %) |
Feb 24 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 97.52 | 1,849 | 180,314 | 113,034 | 114.9 K to 113 K (-1.61 %) |
Feb 24 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 99.12 | 906 | 89,803 | 114,883 | 115.8 K to 114.9 K (-0.78 %) |
Feb 24 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 99.85 | 945 | 94,358 | 115,789 | 116.7 K to 115.8 K (-0.81 %) |
Feb 24 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 101.06 | 300 | 30,318 | 116,734 | 117 K to 116.7 K (-0.26 %) |